








 Aortic valve replacement (AVR) is the best long-term treatment for aortic valve disease. 
There are many surgical approaches to AVR and with the advancement of technology, less 
invasive treatment modalities are becoming a more popular option for patients.  Currently, 
discussion around minimally invasive approaches are incorporated during the consent 
process with patients, and in some high-volume centres with experienced surgeons, the 
minimal access approach has now become a popular option.  
Median sternotomy, however, remains the most widely used approach to replace the aortic 
valve and is associated with a low mortality and morbidity in most centres (1).  The current 
patient population has become older and frailer with more complex comorbidities which 
has urged the necessity for less invasive approaches to deal with this universal disease of 
ageing (2). Transcatheter aortic valve implantation (TAVI) is one option in the high-risk 
surgical group which is now a recognized treatment modality for severe aortic stenosis, 
aiming to avoid the high surgical burden of a median sternotomy. Some centres are also 
offering TAVI for intermediate and low risk profile groups, for which the long-term 
outcomes for patients are still unknown (3).  
Minimally invasive aortic valve replacement (MIAVR) is not novel to the specialty. Cosgrove 
et al performed the first MIAVR through a parasternal incision in 1996 (4). This approach 
was followed by AVR via right thoracotomy and an upper hemi-sternotomy (HS) (5, 6).  
Thanks to technological innovations, the instrument set and surgical techniques have moved 
the field forward gradually.  
Minimally invasive surgery (MIS) has gained popularity in the last decade for both patients 
and surgeons.Within the last decade the expansion of sutureless and rapid deployment 
valve design and sutured valves using Cor-Knot have made MIS approaches easier to learn 
and more convenient with suitability for both low and high-risk patients alike. In order for 
MIS to become the standard surgical approach the techniques must be reproducible and as 
safe as surgery via a median sternotomy.  
In this article, we present our institutional learning curve and surgical outcomes for both 
anterior right thoracotomy (ART) and hemi-sternotomy. We aim to demonstrate the safety 
of moving to MIAVR compared to a median sternotomy (MS).  
 
Patients and Methods: 
Inclusion criteria 
All patients who underwent isolated first time AVR between May 2015 and May 2019 were 
included in the study. The choice of procedure was determined by the operating surgeons’ 
usual practice and whether or not the patient opted for a minimal access approach. Those 
patients who were offered ART had a computed tomography (CT) angiogram of the entire 
aorta down to the femoral arteries to assess their suitability for an ART approach and safe 
femoral cannulation.   
Exclusion criteria 
All patients who required combination or redo procedures were excluded. Patients with an 
unsuitable aorta-vascular tree (heavily calcified vessels or femoral arteries less than 6mm) 
were excluded from the ART approach.  
 
Methods 
All data was extracted retrospectively from our prospectively collected database, we 
categorized the data by surgical approach into conventional median sternotomy, hemi-
sternotomy and anterior right thoracotomy (ART). Statistical testing was undertaken using 
Chi-squared test for categorical variables or a one-way Anova with Tukey post-hoc pairwise 




All patients underwent a routine preoperative workup which included: clinical examination, 
routine bloods, chest X-ray, 12 lead ECG, coronary angiogram when indicated and an 
anaesthetic review. Patients listed for ART underwent CT angiogram of the aorta with a 
follow through to the femoral arteries to assess the suitability for ART including peripheral 
cannulation. Femoral artery size of 7 mm and above was reassuring for arterial cannulation 
with a size 21 cannula. Smaller femoral arteries and/or a pressure higher than 300 mmHg in 
the arterial inflow was an indication for bilateral femoral artery cannulation. Aortic 
calcifications (e.g. porcelain aorta) was also assessed in the CT scan. 
 
Surgical techniques of the MIAVR group 
ART Setup 
Anaesthetic Preparation 
All patients underwent a routine general anaesthetic with a single lumen endotracheal tube; 
a bronchial blocker to the right main bronchus was inserted to achieve a satisfactory view 
with right lung deflation. In all MIAVR cases a four-lumen central venous catheter, left radial 
arterial monitoring line, external defibrillator pads and continuous cerebral oximetry 
monitoring were used. Transoesophageal echocardiogram (TOE) was applied in all cases and 
was used to guide cannulation and monitor for retrograde aortic dissection specifically with 
the ART approach.  In our institution ultrasound scanning of the femoral arteries and veins is 
performed routinely prior to femoral vessels cannulation. 
 
Positioning the Patients 
All patients undergoing sternotomy or hemi-sternotomy were positioned in supine position 
with a sandbag across both shoulders. In the case of ART, an inflatable bag behind the right 
hemithorax at the level of the third intercostal space was used to achieve a 30-degree tilt 
and spread the rib space. 
 
Cannulation strategy 
In all MS and HS cases, conventional central cannulation techniques were used. Both non-
selective and selective antegrade cardioplegia were used. Left ventricle was vented using a 
right superior pulmonary vein vent. Cross clamping was achieved using a variety of standard 
cross clamps. In ART cases, peripheral cannulation using the femoral artery and vein was 
utilized. The side of cannulation was determined according to the preoperative CT scan and 
intra-operative ultrasound. Femoral cannulation was performed with a cut down using 
Seldinger technique under TOE guidance. Both body surface area (BSA) and arterial 
diameter were used to determine the size of Biomedicus, Medtronic cannula selected (size 
ranges between 19 and 23 French). A multistage venous cannula (Medtronic Bio-medicus) 
was used for venous cannulation. A non-selective aortic root cardioplegia cannula was 
inserted and a right superior pulmonary vein vent into the left ventricle. A Chitwood clamp 
inserted thorough the right second intercostal space at the anterior axillary line was used to 
cross clamp the aorta.   
 
Incision, exposure and closure 
In HS cases, we made a J-shaped sternotomy to the level of third or fourth intercostal space. 
In ART cases, an oblique 5 cm skin incision on-top of the 3rd rib was performed, followed by 
blunt dissection of the pectoralis major parallel to the direction of its fibers to the upper 
border of the 3rd rib. The pleural space was entered after right lung deflation then, the 
internal mammary vessels were identified, double clipped then divided. The third rib was 
disarticulated from the sternum using a sternal saw. A soft tissue retractor (Alexis) was 
used then gently spread the ribs using a Thoratrack (Medtronic) retractor. The pericardium 
was opened after commencing cardiopulmonary bypass (CPB). 
In both MS and HS, closure was carried out in the standard fashion using stainless steel 
wires. In ART cases, pericardium was closed after decannulation. Two Blake chest drains 
were inserted in the both the pericardium and right pleural space. The third rib was sutured 
to the sternum with a single number 4-Ethibond suture. The remainder of the incision was 
closed in layers. 
Results 
A total of 661 patients underwent isolated first time AVR between May 2015 and May 2019, 
of which 429 (65%) underwent MS, 126 (19%) had HS and 106 (16%) had ART. Preoperative 
characteristics (age, gender, angina class, dyspnoea class, diabetes, smoking history renal 
failure, pre-operative heart rhythm and ejection fraction) showed no statistical significant 
difference (see table 1). Unfortunately, the EuroSCORE was not calculated in all patients in 
our database despite the complete data of its individual components. Hence, we opted not 
to include it in the preoperative patient characteristics  
 
Intraoperatively, CBP times were significantly higher in all MIAVR groups compared with MS. 
Further comparative tests showed that the CPB times in the ART group were significantly 
higher than in the HS group (p value 0.001). Furthermore, Cross clamp times were also 
significantly higher in the MIAVR group compared to MS. The HS- versus ART subgroup 
analysis showed a shorter cross clamp time (p value 0.004). Valve selection as regards to 
type (mechanical or biological) was of no statistically significant difference, the data for 
valve sizes was not complete so was not analyzed. There were 7 (6.6%) conversions in the 
ART group to a full sternotomy including intra-operative conversion and re-exploration for 
bleeding or tamponade, the conversion data for HS was not recorded accurately and hence 
unreliable. Potential hemisternotomy conversions were included in the median sternotomy 
group (table 2).  
 
Postoperatively, there was no mortality within the hospital stay in both HS and ART groups. 
Seven patients died in the MS group, one patient died of intractable ventricular fibrillation, 
two patients died of respiratory failure, the others died of, bowel ischaemia, upper gastro-
intestinal bleeding, post-operative low cardiac output syndrome resulted in multiorgan 
failure, and after having a large cerebro-vascular event immediately after the surgery.  The 
overall mortality of all patients was 1.06%. There were no new post-operative strokes in the 
ART group, two patient developed stroke in the HS group and six in the MS group. However, 
this was not statistically significant across the three groups (p-value 0.70). The HS group 
showed the shortest overall hospital stay whereas MS had the longest hospital stay. The 
most significant difference in the overall stay was between HS and MS groups (p=0.001). 
The ICU stay and postoperative ventilation time was the shortest in the HS group and the 
longest in the MS group but, this was not significant (p value 0.26). All patients in the ART 
group were extubated within 24 hours. The postoperative pulmonary complications, gastro-
intestinal complications and new renal failure were not significant across all groups (p value 
0.40, 0.90 and 0.34 respectively). Blood loss was less in the HS group followed by ART then 
MS groups. This difference was significant between HS and MS groups (p value 0.004). The 
difference between the ART group and HS group was even less significant (p value 0.571) 
despite trend towards reduced blood loss. Both postoperative blood transfusion and return 
to theatre were not different amongst the three groups (p value 0.102 and 0.54 
respectively). Post-operative arrhythmia had a lower occurrence in the ART group compared 
to the other two groups. The most significant difference was between the ART group and 
MS group (p value 0.004). Furthermore, there were less arrhythmias in HS group compared 
to MS group (p = 0.031). There was a slight tendency towards less arrhythmia in the ART 
group compared to HS group (p value 0.28) (table 3). 
 
Discussion 
Aortic stenosis represents a major health burden in developed countries, especially among 
the elderly and frail population (7).  Aortic valve replacement remains the best long term 
treatment for severe aortic stenosis and represents a major proportion of adult cardiac 
surgical practice worldwide (8). Median sternotomy is still the most utilized approach for 
surgical AVR (SAVR). Despite its physiologic burden, it is a very effective operation 
associated with low mortality and morbidity with improved symptoms and quality of life as 
shown in the German registry (1).  MIAVR is now becoming more popular for both surgeons 
and patients. This has resulted in evolution of the surgical techniques of SAVR from MS to 
the growing use of HS and ART with the ultimate goal to move to totally endoscopic AVR. 
In this study, we have compared two other approaches for SAVR in comparison to MS. The 
first approach was HS which has been utilized for longer and the second approach was ART 
which is less utilized as surgeons are still navigating their learning curves in our institution.  
Our results showed no statistically significant difference in between the three groups in 
terms of mortality, stroke, renal failure and gastrointestinal complications. The intensive 
care length of stay was not different between three groups however, the total length of 
hospital stay was significantly less in the HS compared to MS group but not between ART 
and MS or ART and HS. Other studies have demonstrated shorter times in their ART group 
(9) 
Blood loss was significantly less in the HS compared to the MS but not between the other 
groups. There was no difference in the rate of blood or blood product transfusion.  
Additionally, the rate of re-exploration for bleeding was similar. Other studies, however, 
have showed less blood loss and transfusion requirements in their ART patients compared 
to MS and HS (10, 11), Conversion to sternotomy was precisely documented in the ART 
group, but this was not the case in the HS group. This one of the limitations in this study.  
A total of five patients in the ART group had a sternotomy when they were re-explored 
including one patient who was not stable enough to transfer to theatre and was initially  
re-explored via the ART wound for relief of tamponade.  Furthermore, we had two intra-
operative conversions due to poor access to the valve. The conversion rate was very 
different for surgeons and one surgeon stopped offering the ART procedure due to a high 
conversion rate. This does suggest that the ART approach may not suit all surgeons (12) and 
regular audit of results is recommended (13).  
Interestingly, pulmonary complications were least in the ART group despite the fact that 
ventilation times were higher, however, the difference was not significant.  We expected 
the ventilation time to be shorter in the MIAVR as was shown by other studies (14-16). One 
reason for this finding could be due to our departmental policy of requiring a chest X-Ray to 
ensure lung re-expansion prior to extubation.  We are currently implementing an enhanced 
recovery program for all SAVR patients to ensure shorter ventilation times and hence, 
shorter ICU stay. Of note, post-operative atrial fibrillation (AF) rates were significantly lower 
in the ART compared to the MS group but not between HS and MS or HS and ART. These 
findings may reflect the minimal manipulation of the heart in that group of MIAVR as well as 
the adequacy of myocardial protection. Other studies also report the same outcome (9) 
Another advantage for MIAVR is that patients experience less post-operative pain; this was 
demonstrated in a randomized controlled trial by Borger and colleagues and a metanalysis 
by Brown et al in 2009 (17).  Unfortunately, we did not measure pain scores in our patients 
and hence cannot comment on this. Further studies support early active return to work 
using the mini sternotomy approach(18).  In 2016, Ghanta et al also demonstrated the fiscal 
advantages associated with less ventilation time, less intensive care (ICU) and total length of 
hospital stay(HLOS) and fewer blood transfusion requirements (19).  
Of note, the heterogeneity in results between different centres applying MIS most likely 
represents the lack of a structured learning curve and the retrospective nature of the 
studies with its inherent bias and the small sample size in individual centres (20). 
 
Future Progress 
Many studies have criticized ART procedures over the past decade due to the prolonged CPB 
and cross clamp times. Although our results do show longer operative times, importantly, 
this does not translate to more post-operative complications or increased mortality which is 
supported by other groups in the literature (17). Furthermore, recent studies have shown 
comparable and sometimes shorter CPB and cross clamp times to conventional median 
sternotomy. This discrepancy in results could be attributed to the level of experience of the 
different surgical teams performing the procedure. Naturally, the conclusion is that the 
shorter the learning curve of the surgeon the better their operative times will be.  
Another criticism was the routine use of retrograde CPB in ART procedures which is thought 
to increase the incidence of stroke. Our results show that there is no statistical difference in 
stroke rate in all patients. In fact, there was no new stroke incidences in the ART group.  
A further criticism was the limited view of the operative field and the need to shift to long 
shafted instruments. Surgeons, however, with the correct training on equipment adapt well 
and are able to improve their operative times and results with experience. This ability to 
adapt to new instruments and a smaller operative field would also facilitate the transition to 
total endoscopic procedures.  
 
Our study has a few limitations. The retrospective nature of the study which has led to the 
lack of collection of some relevant data. Euroscore as well as valve sizes data were not 
complete, we were unable to identify conversions to sternotomy in the HS group. 
Furthermore, we did not collect echocardiographic outcome data beyond the intra-
operative TOE as patients are usually followed up by the cardiologists in their local hospitals. 
Another limitation was the small number of patients in both HS and ART groups compared 
to midline sternotomy. These limitations urge the need for a prospective randomized 







Based on our experience we believe that it is safe to start a minimally invasive surgical aortic 
valve replacement program with non-inferior mortality and morbidity to the conventional 
median sternotomy approach. Hemisternotomy, in our study, has better outcomes than 
traditional full median sternotomy.  A multi-centre randomized control trial may be required 
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